Singapore's COVID‐19 Genomic Surveillance Programme: Strategies and Insights
Author Information
Author(s): Tan Hao Yi, Khamis Nur Huda, Goh Alvin, Mah Tania K. L., Yeo Benny, Ngan Jie Yin, Ding Yichen, Lin Cui, Chae Sae-Rom, Lee Phoebe, Ho Zheng Jie Marc
Primary Institution: Ministry of Health Singapore
Hypothesis
How did Singapore's genomic surveillance strategy impact public health during the COVID-19 pandemic?
Conclusion
Genomic surveillance was integral in Singapore's COVID‐19 response, guiding timely public health decisions and supporting proactive measures.
Supporting Evidence
- Over 54 weeks, 18,918 samples were sequenced, revealing 29% imported and 71% local cases.
- Severe cases accounted for 12% of the total samples, primarily among the elderly.
- The study identified 11 predominant variants and 288 subvariants during the surveillance period.
Takeaway
This study shows how Singapore used genomic surveillance to track COVID-19 variants and make smart health decisions, helping to keep people safe.
Methodology
The study involved whole genome sequencing of COVID-19 positive samples collected from acute respiratory infection cases over 54 weeks.
Potential Biases
The sampling strategy prioritized severe cases, which may have skewed the understanding of variants causing milder infections.
Limitations
The study focused on severe cases, potentially missing data on milder cases, and faced challenges with sample collection as the pandemic progressed.
Participant Demographics
{"total_cases":18507,"imported_cases":5384,"local_cases":13123,"severe_cases":2204,"gender_distribution":{"male":53,"female":47},"ethnicity_distribution":{"Chinese":62,"Malay":13,"Indian":15,"Others":10}}
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website